Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 6/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylacetohydroxamic Acid SCHEMBL8893714 | 0.98 | HDAC8 (0.95) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL4581295 | 0.88 | HDAC8 (0.78) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL4580449 | 0.88 | HDAC8 (0.78) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL8664637 | 0.87 | KMT2A (0.77) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL16050194 | 0.87 | HDAC8 (0.75) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL4579041 | 0.87 | HDAC8 (0.75) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL16050112 | 0.87 | HDAC8 (0.75) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL14811482 | 0.87 | HDAC8 (0.79) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL10447485 | 0.85 | HDAC8 (0.73) | HDAC8HDAC6MEN1KMT2AHDAC2 | |
| SCHEMBL4821967 | 0.84 | MEN1 (0.72) | HDAC8HDAC6MEN1KMT2AHDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634703-B1 | PROCESS FOR SUPERCRITICAL OR SUBCRITICAL PARTIAL DELIGNIFICATION AND FILLING OF A LIGNOCELLULOSIC MATERIAL | SAS WOODOO (FR) | 2025-04-23 | — | — | EP | claimed |
| US-11820041-B2 | Process for supercritical or subcritical partial delignification and filling of a lignocellulosic material | SAS WOODOO (FR) | 2023-11-21 | — | — | US | claimed |
| US-20200164542-A1 | PROCESS FOR SUPERCRITICAL OR SUBCRITICAL PARTIAL DELIGNIFICATION AND FILLING OF A LIGNOCELLULOSIC MATERIAL | SAS WOODOO (FR) | 2020-05-28 | — | — | US | claimed |
| CN-106916073-A | A kind of synthetic method of hordenine hydrochloride | 上海巧坤化工科技有限公司 | 2017-07-04 | — | — | CN | claimed |
| US-20150038330-A1 | Chemical Compositions and Methodology to Enhance Plant Growth and Development | MCDANIEL ROBERT GENE (US) | 2015-02-05 | — | — | US | claimed |
| EP-2227233-A2 | IDO INHIBITORS | Newlink Genetics (US) | 2010-09-15 | — | — | EP | claimed |
| WO-2009073620-A2 | IDO INHIBITORS | NEWLINK GENETICS (US) | 2009-06-11 | — | — | WO | claimed |
| EP-1948164-A1 | PHARMACEUTICAL COMPOSITIONS OF MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES, LTD. (IN) | 2008-07-30 | — | — | EP | claimed |
| EP-1888525-A1 | 3,6-DISUBSTITUTED AZABICYCLO [3.1.0]HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2008-02-20 | — | — | EP | claimed |
| EP-1797040-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2007-06-20 | — | — | EP | claimed |
| WO-2007045979-A1 | PHARMACEUTICAL COMPOSITIONS OF MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2007-04-26 | — | — | WO | claimed |
| WO-2006117754-A1 | 3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-11-09 | — | — | WO | claimed |
| WO-2006035303-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-06 | — | — | WO | claimed |
| US-20030215781-A1 | Protective solutions for organs | DR. FRANZ KOEHLER CHEMIE GMBH (DE) | 2003-11-20 | — | — | US | claimed |
| EP-1362511-A1 | Protective solution for preventing ischaemia | Dr. Franz Köhler Chemie GmbH (DE) | 2003-11-19 | — | — | EP | claimed |
| EP-1265855-A1 | NOVEL CD23 INHIBITORS | SMITHKLINE BEECHAM PLC (GB) | 2002-12-18 | — | — | EP | claimed |
| WO-2001062715-A1 | NOVEL CD23 INHIBITORS | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-30 | — | — | WO | claimed |
| JP-55062050-A | — | — | None | — | — | JP | disclosed |
| US-4092430-A | ANTICOAGULANTS, ANALGESTIC, ANTIPYRETIC ACTIVITY | CIBA-GEIGY CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4092430-A | ANTICOAGULANTS, ANALGESTIC, ANTIPYRETIC ACTIVITY | CIBA-GEIGY CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030215781-A1 | Protective solutions for organs | GLS, CA1, SI | HDAC8 95/4885HDAC6 365/4885MEN1 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.